Atherosclerosis
Volume 204, Issue 2 , Pages 372-380 , June 2009

Acetaldehyde stimulates monocyte adhesion in a P-selectin- and TNFα-dependent manner

Received 13 August 2008 ,Revised 29 September 2008 ,Accepted 3 October 2008.

References 

  1. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1990;1:342–348
  2. Poikolainen K. Alcohol mortality: a review. Journal of Clinical Epidemiology. 1995;48:455–465
  3. NIAAA . NIAAA Council approves definition of binge drinking. NIAAA Newsletter. 2004;1
  4. Kauhanen J, Kaplan GA, Goldberg DD, Cohen RD, Lakka TA, Salonen JT. Frequent hangovers and cardiovascular mortality in middle-aged men. Epidemiology. 1997;8:310–314(Cambridge, Mass)
  5. McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ. 1997;314:1159–1164(Clinical research ed.)
  6. Mukamal KJ, Maclure M, Muller JE, Mittleman MA. Binge drinking and mortality after acute myocardial infarction. Circulation. 2005;112:3839–3845
  7. Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. British Heart Journal. 1992;68:443–448
  8. Isse T, Matsuno K, Oyama T, Kitagawa K, Kawamoto T. Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. Alcoholism, Clinical and Experimental Research. 2005;29:1959–1964
  9. Tsukamoto S, Muto T, Nagoya T, Shimamura M, Saito M, Tainaka H. Determinations of ethanol, acetaldehyde and acetate in blood and urine during alcohol oxidation in man. Alcohol Alcohol. 1989;24:101–108
  10. Korsten MA, Matsuzaki S, Feinman L, Lieber CS. High blood acetaldehyde levels after ethanol administration. Difference between alcoholic and nonalcoholic subjects. The New England Journal of Medicine. 1975;292:386–389
  11. Eriksson CJ. The role of acetaldehyde in the actions of alcohol (update 2000). Alcoholism, Clinical and Experimental Research. 2001;25:15S–32S
  12. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2−/−mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894–897
  13. Ley K, Bullard DC, Arbones ML, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. The Journal of Experimental Medicine. 1995;181:669–675
  14. Norman MU, Lister KJ, Yang YH, Issekutz A, Hickey MJ. TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation. British Journal of Pharmacology. 2005;144:265–274
  15. Ross R. Atherosclerosis—an inflammatory disease. The New England Journal of Medicine. 1999;340:115–126
  16. Redmond EM, Cullen JP, Cahill PA, et al. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1. Circulation. 2001;103:597–603
  17. Laudanski K, De A, Pellegrini J, Miller-Graziano C. Simultaneous aberrations in Mphi and T cell function adversely affect trauma patients’ clinical outcome: a possible faulty IL-13 feedback loop. Clinical Immunology. 2006;118:332–341
  18. Cullen JP, Sayeed S, Jin Y, et al. Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells. American Journal of Physiology. 2005;289:H1669–1675
  19. Vrsalovic M, Vrsalovic MM, Presecki AV, Lukac J. Modulating role of alcohol and acetaldehyde on neutrophil and monocyte functions in vitro. Journal of Cardiovascular Pharmacology. 2007;50:462–465
  20. Haorah J, Heilman D, Knipe B, et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcoholism, Clinical and Experimental Research. 2005;29:999–1009
  21. Hendrickson RJ, Cahill PA, Sitzmann JV, Redmond EM. Ethanol enhances basal and flow-stimulated nitric oxide synthase activity in vitro by activating an inhibitory guanine nucleotide binding protein. The Journal of Pharmacology and Experimental Therapeutics. 1999;289:1293–1300
  22. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 2000;101:2290–2295
  23. Nageh MF, Sandberg ET, Marotti KR, et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1517–1520
  24. Hayasaki T, Kaikita K, Okuma T, et al. CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. Circulation Journal. 2006;70:342–351
  25. Furukawa Y, Matsumori A, Ohashi N, et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circulation Research. 1999;84:306–314
  26. Hsiang CY, Wu SL, Cheng SE, Ho TY. Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells. Journal of Biomedical Science. 2005;12:791–801
  27. Nakamura Y, Yokoyama H, Higuchi S, Hara S, Kato S, Ishii H. Acetaldehyde accumulation suppresses Kupffer cell release of TNF-Alpha and modifies acute hepatic inflammation in rats. Journal of Gastroenterology. 2004;39:140–147
  28. Gosepath J, Brieger J, Muttray A, et al. mRNA induction and cytokine release of inflammatory mediators during in vitro exposure of human nasal respiratory epithelia to acetaldehyde. Inhalation Toxicology. 2006;18:1083–1090
  29. Schleser S, Ringseis R, Eder K. Conjugated linoleic acids have no effect on TNF alpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis. 2006;186:337–344

PII: S0021-9150(08)00699-0

doi: 10.1016/j.atherosclerosis.2008.10.008

Atherosclerosis
Volume 204, Issue 2 , Pages 372-380 , June 2009

Article Tools

* Image Usage & Resolution